SCHEMBL4549798

SCHEMBL4549798

CCCCOc1c(C(=O)OCC)occ(Br)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 4/20 0.41
THRB P10828 4/20 0.41
ESR1 P03372 3/20 0.39
MAOB P27338 1/20 0.36
ALDH1A1 P00352 3/20 0.35
POLB P06746 2/20 0.35
KMT2A Q03164 5/20 0.35
HSD17B10 Q99714 2/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 4/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MAPT P10636 2/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4549706 0.88 THRA (0.42) THRATHRBESR1MAOBALDH1A1
SCHEMBL15143769 0.85 MAOB (0.48) MAOBALDH1A1KMT2AHSD17B10GAA
SCHEMBL16181519 0.85 KDM4E (0.37) ESR1MAOBALDH1A1KMT2AHSD17B10
SCHEMBL16925415 0.85 THRA (0.47) THRATHRBESR1KMT2AMEN1
SCHEMBL29344948 0.83 MAOB (0.40) ESR1MAOBALDH1A1POLBKMT2A
SCHEMBL15928418 0.83 MAOB (0.40) THRATHRBESR1MAOBALDH1A1
SCHEMBL17928516 0.82 MAOB (0.42) MAOBALDH1A1HSD17B10MAPTTSHR
SCHEMBL4545475 0.80 LMNA (0.43) THRATHRBMAOBALDH1A1KMT2A
SCHEMBL2601701 0.80 MAOB (0.45) MAOBALDH1A1KMT2AHSD17B10MAPT
SCHEMBL15928438 0.79 MAOB (0.40) MAOBALDH1A1KMT2AHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540720-A1 1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE DERIVATIVE AND USE OF SAME AS HIV INTEGRASE INHIBITOR Japan Tobacco, Inc. (JP) 2013-01-02 EP disclosed
US-20120108564-A1 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor JAPAN TOBACCO INC. (JP) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108564-A1 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor IMPDH1, IMPA1, DPYD THRA 3648/4885THRB 3605/4885ESR1 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.